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Abstract
Background: Successful implementation of rapidly advancing regenerative medicine approaches has led to high
demand for readily available cellular suspensions. In particular, multipotent stromal cells (MSCs) of placental origin have
shown therapeutic efficiency in the treatment of numerous pathologies of varied etiology. Up to now, cryopreservation
is the only effective way to preserve the viability and unique properties of such cells in the long term. However,
practical biobanking is often associated with repeated temperature fluctuations or interruption of a cold chain due to
various technical, transportation, and stocking events. While biochemical processes are expected to be suspended
during cryopreservation, such temperature fluctuations may lead to accumulation of stress as well as to periodic
release of water fractions in the samples, possibly leading to damage during long-term storage.
Methods: In this study, we performed a comprehensive analysis of changes in cell survival, vital parameters, and
differentiation potential, as well as transgene expression of placental MSCs after temperature fluctuations within the
liquid nitrogen steam storage, mimicking long-term preservation in practical biobanking, transportation, and temporal
storage.
Results: It was shown that viability and metabolic parameters of placental MSCs did not significantly differ after
temperature fluctuations in the range from –196 °C to –100 °C in less than 20 cycles in comparison to constant
temperature storage. However, increasing the temperature range to –80 °C as well as increasing the number of cycles
leads to significant lowering of these parameters after thawing. The number of apoptotic changes increases depending
on the number of cycles of temperature fluctuations. Besides, adhesive properties of the cells after thawing are
significantly compromised in the samples subjected to temperature fluctuations during storage. Differentiation
potential of placental MSCs was not compromised after cryopreservation with constant end temperatures or with
temperature fluctuations. However, regulation of various genes after cryopreservation procedures significantly varies.
Interestingly, transgene expression was not compromised in any of the studied samples.
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Conclusions: Alterations in structural and functional parameters of placental MSCs after long-term preservation should
be considered in practical biobanking due to potential temperature fluctuations in samples. At the same time,
differentiation potential and transgene expression are not compromised during studied storage conditions, while
variation in gene regulation is observed.
Keywords: Placenta, Amnion, Cryopreservation, MSC, Biobanking, Cryomicroscopy, Viability, Mimicking long-term
storage, Temperature fluctuations
Background
Recent advances in cellular therapy, regenerative medi-
cine, and stem cell research have substantially increased
the need for various types of readily available cellular sus-
pensions, but in particular the need for multipotent stro-
mal cells (MSCs). Numerous clinical trials have proved
the efficiency of the application of MSCs in the treatment
of various severe pathologies, wound healing, and regula-
tion of the endocrine system [1–3]. In addition, progress
in the development of biocompatible materials opens
great potential for the application of MSCs in tissue engin-
eering due to the high differentiation potential and prolif-
eration capacity of these cells [4, 5].
While numerous organs and tissues can serve as a
source of MSCs, various components of placenta are
among the most prolific for application in regenerative
medicine [6–8]. MSCs of placental origin can be derived
from placental villi, placental membranes, umbilical cord
cells, and Wharton’s jelly [9–11]. Among the major ad-
vantages of placenta as a source of MSCs are the oppor-
tunity to recover a large amount of initial material, the
possibility of obtaining autologous material without in-
vasive surgery, and the relative simplicity of retrieving
high amounts of the cells [12]. Furthermore, the devel-
opmental origin of placental tissues, being partially ma-
ternal and partially fetal [13], allows us to receive two
different patient-specific materials at the same time, one
for the fetus and the other for the mother.
Development of storage and transportation protocols
is the crucial condition for the clinical application of pla-
cental MSCs. Presently, application of low-temperature
storage technologies is the only effective approach for
the long-term preservation of various cell suspensions
and other biomaterials [14, 15]. In order to be clinically
sufficient, such technologies should not only provide a
high viability of the preserved material, but also comply
with modern Good Manufacturing Practice (GMP) stan-
dards [16, 17]. In our previous work we discussed the
importance and demonstrated possibilities for the
utilization of low-temperature storage technologies with
materials and equipment approved for medical practice
[18]. Furthermore, we have demonstrated generation
and cryopreservation of alginate scaffolds with placental
MSCs in an animal model [19, 20].
Temperature regime is one of the key components of
the cryopreservation procedure [21]. For the purposes of
long-term preservation it is generally accepted to freeze
suspensions of MSCs at the rate of 1 °C/min down to –
80 °C with immersion into liquid nitrogen [22]. Long-
term storage of biological material in liquid nitrogen is
by far the most practical and reliable method since the
temperature of liquid nitrogen is constant. At the same
time, practical functioning of low-temperature banks
often requires frequent access to material and may be
accompanied by various technical, stocktaking, and
other events that may be associated with temperature
fluctuations due to changes in the location of storage of
biological objects, their transportation, and similar alter-
ations. Therefore, even with modern biobanking
technology, repeated temperature fluctuations or inter-
ruption of a cold chain may occur during maintenance
and handling.
During cryopreservation, biochemical and cellular pro-
cesses are anticipated to be on hold for a virtually infin-
ite time. However, fluctuations of the temperature may
lead to accumulation of stress in samples [23] or to peri-
odic release of unfrozen bound water fractions [24], pos-
sibly compromising survival and vital parameters of
cells. Therefore, such fluctuations could be a main factor
in potential damage during long-term storage of cryo-
preserved biomaterial. At the same time, there is a lack
of information and studies which focus on the analysis
of this problem.
In addition to viability and overall structure-
functional parameters, cryopreservation can also influ-
ence certain other cellular pathways and molecular
mechanisms [25]. Wide application of modern mo-
lecular biology methods in stem cell research, e.g.,
generation of induced pluripotent stem cells, often
implies overexpression of certain genes and other
genetic manipulations. Besides, potential clinical appli-
cation of MSCs may involve various differentiation
procedures. While there are only a handful of works
on the analysis of the influence of cryopreservation
on gene expression in modified cells and cellular dif-
ferentiation potential [26, 27], the influence of pos-
sible temperature fluctuations on these parameters
remains unclear.
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According to previously obtained data, temperature
fluctuations in the steam storage device can range within
–180 °C to –150 °C; rarely, in emergency situations, the
temperature can rise to –130 °C. Moreover, the dry ice
temperature of –78.5 °C or refrigeration equipment with
a temperature of –80 °C are often used for transporta-
tion of biological samples or for temporary storage.
The aim of this study was to perform a comprehensive
analysis and comparative characterization of possible
changes in vital parameters and differentiation potential,
as well as transgene expression of placental MSCs during
temperature fluctuations within liquid nitrogen steam
storage. Such an approach would mimic long-term preser-
vation within the realities of practical biobanking, possible




Placental amnion cells were isolated via application of a
standard enzymatic method followed by characterization
for MSC origin as described previously [5]. The obtained
placental MSCs were subjected to differentiation by cul-
turing in corresponding media as well as to genetic
modification via transduction. Native and modified pla-
cental MSCs were frozen with a freezing protocol gener-
ally accepted for adherent stromal cell suspensions [22].
Part of the samples was subjected to repeated
temperature fluctuations in the subzero range. The sam-
ples were comprehensively analyzed for characteristics
of vital parameters, differentiation potential, and trans-
gene expression after cryopreservation at a constant end
temperature in comparison to cryopreservation with
temperature fluctuations. All experiments were per-
formed on the samples derived from at least three inde-
pendent donors (n ≥ 3).
Cell derivation and cell culture
Cell source, and ethical and legislative statement
Human placenta material was donated in an anonymized
manner with written informed consent of the patients
after routine Caesarian section at the Department of Gy-
naecology and Obstetrics at Hannover Medical School,
Germany (approved by the Ethical Commission of
Hannover Medical School, No. 2396-2014) and in
Kharkiv municipal maternity hospital No.1, Ukraine (ap-
proved by Bioethics Committee of the Institute for Prob-
lems of Cryobiology and Cryomedicine of the National
Academy of Sciences of Ukraine, No. 2-0306-2013). This
study did not involve animal experiments.
Derivation of primary cell culture
Primary culture of MSCs was derived from the amnion
of placenta via application of an enzymatic method [5].
Amnion membranes were washed in phosphate-buffered
saline (PBS) supplemented with 10% ciprofloxacin
(Fresenius Kabi, Bad Homburg, Germany) and then dis-
sected into small pieces and incubated for 1 h at 37 °C
in presence of 0.25% trypsin. After trypsin digestion the
samples were filtered through a 100-μm cell strainer
(BD Biosciences, Durhan, USA), followed by centrifuga-
tion of the obtained cell suspension for 5 min at
1200 rpm (Heraeus Multifuge 1S-R, Thermo Fisher Sci-
entific GmbH, Dreieich, Germany). The supernatant was
removed and the cell pellet was resuspended in MSC
growth medium and plated on 10-cm cell culture dishes
(Cellstar, Greiner BioOne, Frickenhausen, Germany).
Cell culture
Placental MSCs were cultured at 5% CO2 and 37 °C in a
humidified CO2 incubator (Thermo Fisher Scientific
GmbH, Dreieich, Germany) under sterile conditions in
Dulbecco’s modified Eagle’s medium high glucose
(DMEM LG; Lonza, Basel, Switzerland) supplemented
with 1% (v/v) 100 mM sodium pyruvate solution (Lonza,
Basel, Switzerland), 10% (v/v) fetal bovine serum (FBS;
Lonza, Basel, Switzerland), 1% (v/v) antibiotic-
antimycotic solution (BioWest, Nuaillé, France), and 1%
(v/v) ascorbic acid (Sigma-Aldrich, St. Louis, USA) in
10-cm tissue culture plates (CELLSTAR®, Greiner
BioOne, Frickenhausen, Germany). Harvesting of the
cells was performed with application of 0.25% trypsin
solution.
Characterization of multipotent stromal cells
Reverse transcription polymerase chain reaction for MSC
markers
Extraction of RNA was performed with the peqGOLD
Total RNA Kit (Peqlab GmbH, Erlangen, Germany) ac-
cording to the manufacturer’s protocol. In brief, the cell
pellet was lysed in 400 μl RNA lysis buffer and trans-
ferred onto a DNA removing column for removal of
contaminant DNA. Following centrifugation at 12,000 ×
g for 1 min, 400 μl of 70% ethanol was added to the flow
through. The obtained lysate was loaded onto a Perfect
Bind RNA Column and centrifuged at 10,000 – g for
1 min in order to bind RNA to the column. The column
was washed once with 500 μl RNA Wash Buffer I and
twice with 600 μl RNA Wash Buffer II. The column was
then dried by centrifugation at 10,000 × g for 2 min. The
total RNA was eluted from the column with 50 μl sterile
RNase-free water. The concentration of RNA was mea-
sured with the NanoDrop photometer ND-1000
(Thermo Fisher Scientific GmbH, Dreieich, Germany).
The RNA was transcribed to complementary DNA
(cDNA) with application of a High Capacity cDNA Re-
verse Transcription Kit (Life Technologies GmbH,
Darmstadt, Germany). The addition of Oligo (dT)
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primers (TIB Molbiol, Berlin, Germany) ensured that
only the mRNA was transcribed.
Analysis of the mesenchymal markers was performed
with the application of reverse transcription polymerase
chain reaction (RT-PCR) set in 30 μl volume per sample
as follows: 24 μl ddH2O (double distilled water), 3 μl 1×
PCR buffer (NEB, Frankfurt, Germany), 1 μl 100 mM
dNTPs (Fermentas, St. Leon-Rot, Germany), 0.5 units
Taq Polymerase (NEB, Frankfurt, Germany), 0.5 μl of
each primer (final concentration 0.3 μM), and 1 μg
cDNA. The thermal cycling protocol included: a pre-
cycling step at 95 °C for 3 min; 35 cycles of denaturation
at 95 °C for 45 s; annealing at 60 °C for 45 s; extension
at 72 °C for 90 s, and a final extension step at 72 °C for
10 min. Oligonucleotides were designed to have a 60 °C
annealing temperature. A summary of the oligonucleo-
tide sequences, product fragment sizes, and accession
numbers is presented in Additional file 1.
Osteogenic, chondrogenic, and adipogenic differentiation
MSCs were differentiated into mesenchymal lineages
by culturing in corresponding adipogenic, osteogenic,
and chondrogenic differentiation media, as described
previously [5].
Osteogenic differentiation was performed by culturing
the cells under corresponding conditions. The cells were
seeded at a 5 × 104 cells/well concentration onto six-well
culture plates (Cellstar, Greiner BioOne, Frickenhausen,
Germany) followed by culturing for 21 days in DMEM
LG (Biochrom AG, Berlin, Germany) supplemented with
20 mM HEPES zwitterionic buffer and 10% FCS
HyClone™, 0.05 mM L-ascorbic acid-2-phosphate
(Sigma-Aldrich, St. Louis, USA), 0.1 μM dexamethasone,
1% (v/v) penicillin/streptomycin and 3 mM sodium dihy-
drogen phosphate monohydrate (Carl Roth GmbH,
Karlsruhe, Germany). Mineralization of cells differenti-
ated into osteoblasts was detected by Von Kossa staining
after 21 days. In brief, differentiated mineralized cells
were washed two times with PBS and fixed with 10% for-
malin, then washed once with PBS and twice with
ddH2O followed by the addition of 1% silver nitrate
(Riedel de Haen GmbH, Germany). The cell culture dish
was exposed to sunlight for 30 min, washed with
ddH2O, and stained with 5% sodium thiosulfate (Sigma-
Aldrich, St. Louis, USA) for 5 min, followed by a final
rinse with ddH2O. Mineralization was visualized with a
bright field Keyence Biozero microscope.
Chondrogenic differentiation was performed by pellet-
ing 2.5 × 105 cells/well by centrifugation for 5 min at
200 × g in v-shaped 96-well plates (Cellstar, Greiner
BioOne, Frickenhausen, Germany) with further culturing
in corresponding differentiation media for 21 days. The
differentiation medium consisted of DMEM HG culture
medium ((Biochrom AG, Berlin, Germany) supplemented
with 20 mM HEPES buffer, 1% (v/v) penicillin/strepto-
mycin, 1% (v/v) ITS Universal Cell Culture Supplement
Premix (Becton Dickinson GmbH, Heidelberg, Germany),
0.1 μM dexamethasone, 0.17 mM L-ascorbin acid-2-
phosphate (Sigma-Aldrich, St. Louis, USA), 0.35 mM L-
proline (Biochrom AG, Berlin, Germany), 1 mM sodium
pyruvate (Biochrom AG, Berlin, Germany), and 10 ng/ml
transforming growth factor-β3 (PeproTech GmbH,
Hamburg, Germany). The differentiation medium was
changed every 3 days. After 21 days, the pellets were fixed
with 10% paraformaldehyde (Carl Roth GmbH, Karlsruhe,
Germany), cut in 7-μm sections and stained with Alcian
blue (Sigma-Aldrich, St. Louis, USA) as an indicator of
sulfated glycosaminoglycan (sGAG)-rich extracellular
matrix.
For adipogenic differentiation the cells were seeded at
a 5 × 104 cells/well concentration onto six-well culture
plates and cultured for 14 days in DMEM supplemented
with 20% FCS HyClone™ (Thermo Fisher Scientific
GmbH, Dreieich, Germany), 20 mM HEPES zwitterionic
buffer (Biochrom AG, Berlin, Germany), 1 μM dexa-
methasone (Sigma-Aldrich, St. Louis, USA), 0.5 mM 3-
isobutyl-1-methylxanthin (Sigma-Aldrich, St. Louis,
USA), 60 μM indomethacin (Sigma-Aldrich, St. Louis,
USA), 1% (v/v) penicillin/streptomycin (Biochrom AG,
Berlin, Germany), and 10 μg/ml insulin (Sigma-Aldrich,
St. Louis, USA). After 14 days the cells were stained with
Oil Red O for visualization of lipid vacuole formation. In
brief, the cells were washed with PBS, fixed for 20 min
in 10% formalin (Sigma-Aldrich, St. Louis, USA), then
rinsed twice with ddH2O and washed with 50% ethanol
(AppliChem GmbH, Darmstadt, Germany). Lipid vacu-
oles were visualized with a bright field microscope
(Keyence Biozero, Keyence, Osaka, Japan) after 10 min
incubation in Oil Red O (Sigma-Aldrich, St. Louis, USA)
followed by washing with acetone/50% ethanol (Merck
KGaA, Darmstadt, Germany) and a final rinse with
water.
Each differentiation procedure was performed in
triplicate and compared with undifferentiated cells as
controls (n = 3).
Cryopreservation of cells
Placental MSCs were removed from culture plates,
washed from trypsin with a culture medium, and equili-
brated in cryoprotective medium at a concentration of
1 × 106 cells/ml at 20 °C for 15 min. Culture medium sup-
plemented with 10% DMSO (Sigma-Aldrich, St. Louis,
USA) and 10% FBS was used as cryoprotective medium.
The samples were placed in 1.8-ml cryovials (Nunc™
Thermo Fisher Scientific GmbH, Dreieich, Germany) and
cooled in the programmable freezer “ЗП-10” (BioCold
Special Designing and Technical Bureau, Kharkiv,
Ukraine) with a cooling rate of 1 °C/min to –80 °C,
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followed by immersion into the liquid nitrogen within the
storage devices (HB-05; JSC Ural Compressor Plant, Eka-
terinburg, Russia) in standard cassette boxes. The samples
were uniformly distributed in a box and surrounded on all
sides by identical test tubes containing the medium. The
samples were rapidly thawed in the water bath at +37 °C
with subsequent washing of DMSO with a culture
medium. Native cells from the cell culture were used as a
positive control; cells resuspended in 96% ethanol at –18 °
C and kept overnight with further washing with the cul-
ture medium were taken as the negative control.
To assess the impact of temperature fluctuations on
placental MSCs, a method mimicking potential condi-
tions of the practical biobanking was applied. In sum-
mary, the samples were removed from the cryostorage
in standard cassette boxes and kept at +20 °C on a styro-
foam platform to achieve the required temperature
followed by immersion of the cassette with probes in
cryovials back to the liquid nitrogen. The temperature in
the cryovials was monitored with a dual-channel
temperature controller (OWEN TRM 200; OWEN LLC,
Moscow, Russia). Thermocouple sensors were immersed
in the central position of identical cryovials with identi-
cal content. The software of the device manufacturer
(OWEN Process Manager V. 1.2.) was applied for
analysis.
The temperature in the samples was increased to –
80 °C, –100 °C, and –150 °C. The number of
temperature cycles was 5, 10, 20, 30, 40, and 50 for each
temperature range.
Evaluation of cell number, viability, and functional
properties of the cells
The number of cells was counted in the Neubauer he-
macytometer (Marienfeld-Superior, Lauda-Königshofen,
Germany) by staining with methylene blue. The viability
of cells was determined by staining with 0.4% trypan
blue.
In order to detect and distinguish necrotic and apop-
totic processes, which may have been initiated in the
cells by cryopreservation procedures, the cells were ana-
lyzed with application of the APC Annexin V Apoptosis
detection kit with PI (BioLegend, San Diego, USA) ac-
cording to the manufacturer’s protocol. In brief, the cells
were washed twice with cold BioLegend Cell Staining
Buffer, and then resuspended in 100 μl Annexin V Bind-
ing Buffer. Then, 5 μl APC Annexin V and 10 μl propi-
dium iodide (PI) solution were added. Cells were
incubated for 15 min at room temperature (24 °C) in the
dark. Then, 400 μl Annexin V Binding Buffer was added.
Flow cytometry was performed with FACSCalibur™
(Becton Dickinson GmbH, Heidelberg, Germany). This
kit is specifically designed for the identification of apop-
totic and necrotic cells.
Adhesive properties were studied by seeding 2 × 105
cells per well on a six-well plate, and culturing at 5%
CO2 and 37 °C in a humidified CO2 incubator. After
24 h incubation nonattached cells were aspirated and
the remaining adhered cells were detached with 0.25%
trypsin and counted.
The MTT test was used to study metabolic and prolifer-
ation activity of the cells. CellTiter 96® Non-Radioactive
Cell Proliferation Assay (Promega, Fitchburg, USA) was
applied according to the manufacturer’s protocol. In brief,
1 × 104 cells per well were seeded with four parallels for
each sample on a 96-well plate (Cellstar, Greiner BioOne,
Frickenhausen, Germany) and cultivated for 24 h in 100 μl
MSC medium in a humidified CO2 incubator at 37 °C and
5% CO2. After incubation for 24 h, 15 μl MTT reagent
per well was added with incubation for 4 h at 37 °C. Then,
100 μl Stop Mix reagent was added per well and incubated
further for 1 h at room temperature in the absence of
light. Finally, the formazan concentration was measured
with a BioRad-680 microplate reader (BioRad, Munich,
Germany) at the 570 nm wavelength.
The resazurin reduction test was also used for the ana-
lysis of metabolic activity of the cells in order to support
the MTT data. This was performed by plating the cells at
a concentration of 1 × 105 cells/ml per well in 1 ml of cul-
ture medium onto 24-well plates (SPL Life Science,
Pocheon-Si, South Korea) followed by the addition of
200 μl resazurin solution (Sigma-Aldrich, St. Louis, USA)
dissolved in PBS at a concentration of 0.15 mg/ml. The
mixture was incubated for 24 h in a humidified CO2 incu-
bator under standard conditions. The absorption was
measured with a Solar PV 1251C spectrophotometer
(Solar, Minsk, Belarus) at a wavelength of 570 nm.
Cryomicroscopy
Cryomicroscopic studies were performed for visualization
of changes during cryopreservation, temperature fluctua-
tions, and thawing. Placental MSCs were removed from
the culture plates using 0.25% trypsin-EDTA, washed with
PBS, and resuspended in cryopreservation medium. After
15 min of pre-incubation in cryopreservation medium,
50 μl of the cell suspension was collected from the bottom
of the cryotube and pipetted in a cryomicroscopic cham-
ber complex (KP 6; SDTB IPC&C, Kharkov, Ukraine) on
the base of a microscope (MBI 15U 4.2; LOMO, St.
Petersburg, Russia). The samples were covered with glass
slide covers to prevent drying. Freezing was carried out at
1 °C/min down to –100 °C, followed by raising of the
temperature to –80 °C at a rate of 1 °C/min and lowering
back to –100 °C, with this cycling being repeated three
times. The temperature range was selected with respect to
the most significant changes in the cell vital parameters
which were identified in our research and to the capacity
of available cryomicroscopic equipment. Sample was
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thawed at the rate of 1 °C/min until complete melting of
the ice crystals. The sizes of the individual crystals, chan-
nels between the crystals, cells, and cell aggregates were
recorded with a digital camera (UCMOS 3100; SIGETA,
Hangzhou, China) and analyzed with Toup View v.3.7.
(Hangzhou ToupTek Photonics Co. Ltd, Hangzhou,
China) and ImageJ v.1.48 r (NIH, Public domain) software.
Since the sizes of crystals and channels varied widely, the
measurement and analysis was performed on the same el-
ements at different temperatures.
Microarray analysis
mRNA from the samples was purified with the QIAGEN
RNeasy RNA Isolation Kit (QIAGEN, Hilden, Germany)
according to the manufacturer’s protocol. For
minimization of technical variations, each RNA sample
was generated in duplicate and pooled prior to labeling
and hybridizing.
The Microarray utilized in this study represents a re-
fined version of the whole human genome oligo micro-
array 4x44K v2 (Design ID 026652; Agilent
Technologies, Santa Clara, USA) called ‘054261On1M’
(Design ID 066335) developed at the Research Core Unit
Transcriptomics (RCUT) of Hannover Medical School.
Microarray design was created at Agilent’s eArray portal
using a 1 × 1 M design format for mRNA expression as a
template. All noncontrol probes of design ID 026652
have been printed five times within a region comprising
a total of 181,560 features (170 columns × 1068 rows).
Four of these regions were placed within one 1 M region
giving rise to four microarray fields per slide to be hy-
bridized individually (customer specified feature layout).
Control probes required for proper feature extraction
software operation were determined and placed auto-
matically by eArray using recommended default settings.
Synthesis of Cy3- or Cy5-labeled cRNA was performed
with the Low Input Quick Amp Labeling kit, two color
(#5190-2944; Agilent Technologies, Santa Clara, USA)
according to the manufacturer’s recommendations.
cRNA fragmentation, hybridization, and washing steps
were carried out as recommended in the two-color
microarray-based gene expression analysis protocol
V6.7, except that 1000 ng of each fluorescently labeled
cRNA population was used for hybridization.
Slides were scanned on the Agilent Micro Array Scan-
ner G2565CA (pixel resolution 3 μm, bit depth 20). Data
extraction was performed with the feature extraction
software V10.7.3.1 using the extraction protocol file
GE2_107_Sep09.xml, except that the ‘multiplicative
detrending’ algorithm was inactivated.
Measurements of on-chip replicates (quintuplicates)
were averaged using the geometric mean of processed in-
tensity values of the green channel (‘gProcessedSignal’;
(gPS and of the red channel (‘rProcessedSignal’; rPS) to
retrieve one resulting value per channel and unique non-
control probe. Single features were excluded from aver-
aging if they: i) were manually flagged; ii) were identified
as outliers by the feature extraction software; iii) lay out-
side the interval of 1.42 × interquartile range regarding the
normalized gPS distribution of the respective on-chip rep-
licate population; or iv) showed a coefficient of variation
of pixel intensities per feature that exceeded 0.5.
Averaged PS values were normalized by the quantile
normalization approach.
Finally, a lower intensity threshold (surrogate value) was
defined based on the intensity distribution of negative
control features. This value was fixed at 5 normalized PS
units. All measurements below this intensity cutoff were
substituted by the respective surrogate value of 5.
Gene regulation was calculated for the samples differ-
entiated after cryopreservation procedures with constant
temperatures and temperature fluctuations in compari-
son to native cell differentiation.
Transduction of the cells with various constructs
Lentiviral transduction of the cells was performed ac-
cording to standard procedures, as described previously
[28]. In brief, 3.5 × 105 cells were seeded onto six-well
plates 24 h before transduction and cultivated at 37 °C
with 5% CO2. After 24 h the culture medium was re-
placed with fresh MSC medium supplemented with pro-
taminsulfate (8 μg/ml) and the cells were incubated for
30 min prior to transduction at 37 °C with 5% CO2.
Next, the lentivirus-containing supernatant with MOI 1
(multiplicity of infection) was added to the medium.
Two different constructs were used for transduction.
Transduction efficiency was evaluated after 3 days by
measuring the percentage of green fluorescent protein
(GFP)-positive cells with the FACSCalibur™ (Becton
Dickinson GmbH, Heidelberg, Germany) flow cytometer
with the rate of 10,000 events per measurement. Ana-
lysis of cytofluorimetric data was carried out with the
Flowing Software V. 2.1 program.
Construct 1: Lentiviral expression vector construct
pRRL.PPT.T11.EGFP.hPGK.M2.pre (kindly provided
by Michael Morgan, MHH, Hannover, Germany) con-
tained GFP as a reporter gene. Such a construct rep-
resents a chemically inducible system. After
transduction, 48 h of induction with 1 μg/ml doxy-
cycline (Sigma-Aldrich, St. Louis, USA) gives a max-
imum expression level, which returns to background
levels after removing the induction reagent (doxycyc-
line) in approximately 5 days.
Construct 2: Lentiviral expression vector pLVTHM con-
tained GFP as a reporter gene. Lentiviral particles were
produced with application of the DNA-PEI method by
transfecting 6 × 106 of 293 T cells (DSMZ, Braunschweig,
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Germany) with 5 μg psPAX2 encoding gag and pol pro-
teins, and with 5 μg pMD2G containing VSV-G protein.
Transduction was performed in three independent
samples for each construct prior to cryopreservation
procedures and compared with the same noncryopre-
served samples as controls.
Data analysis and statistics
The data was collected from three to five independent
experiments in triplicate (n ≥ 3). Statistically significant
conclusions were obtained by analysis of mean values
and standard deviation calculations (mean ± SD) with
Mann-Whitney criteria and Fisher’s method. Parameter
changes were considered statistically significant at p <
0.05. Statistical calculations and data analysis were per-
formed with the application of Statgraphics V 2.1 soft-
ware (Statpoint Technologies, Inc., Warrenton, USA).
Results
Characterization of cells for MSC origin
Primary cells obtained from placental amnion displayed
typical fibroblast-like spindle-shaped morphology in cell
culture conditions, were adherent to plastic, and capable
of forming a monolayer. RT-PCR analysis revealed that
cells were positive for typical MSC markers, such as
CD90, CD73, CD105, CD106, and CD166, and negative
for the hematopoietic markers CD34 and CD45 as well
as negative for MHC class II (Fig. 1a). In our previous
studies we also confirmed the expression of CD73 and
CD105 markers in these cells at the protein level with
flow cytometry analysis [5, 18]. Furthermore, the cells
were capable of differentiating into adipogenic, chondro-
genic, and osteogenic mesenchymal lineages in corre-
sponding culture conditions (Fig. 1b). Such features are
considered to be sufficient for characterization of a cell
line as MSCs [29].
Analysis of the influence of temperature fluctuations
during low temperature storage on the state of placental
MSCs
Thermograms of temperature fluctuations
To evaluate the actual temperature fluctuations which
may occur in the studied samples during long-term
preservation, we analyzed the thermograms of
temperature changes directly in the samples contained
in cryotubes within standard storage cassette boxes
(Fig. 2). Dynamics of temperature changes in multiple
cycles were studied in the temperature ranges between –
196 °C and –150 °C, –196 °C and –100 °C, and –196 °C
and –80 °C (Fig. 2). Samples from the lower end
temperature in the liquid nitrogen (–196 °C) were freely
thawed at room temperature (20 °C) to the higher end
temperatures of the cycling range (–150 °C, –100 °C,
and –80 °C), followed by immersion into liquid nitrogen
to return to the lower end temperature of the cycle.
Cryomicroscopy
The cell concentration at the bottom of the cryovials
after 15 min was around 6 × 106 cells/ml, while the ini-
tial concentration was 1 × 106 cells/ml, which is ex-
plained by sedimentation of cells at the bottom.
Lowering the temperature down to –100 °C at a rate of
1 °C/min resulted in rapid crystal formation at –11 °C
with generation of a multitude of small 1.4 ± 0.12 μm
crystals with channels in between. The crystal growth
was observed with decreasing temperature, resulting in
the fusion of individual crystals and narrowing of the
channels between the crystals (Fig. 3). The crystals ac-
quired a pointed shape and separate crystals fused
together.
Two types of crystals have been identified: larger crys-
tals in the intercellular space and small crystals located
around the cells. The formation of small crystals, in our
opinion, is related to aspirates of the cell membrane or
the release of water from the cell. The crystals acquire
their final shape and dimensions at –50 °C to –60 °C.
Visually, further cooling did not result in changes in the
crystals. At a temperature of –100 °C large crystals (11.8
± 2.4 μm in width and 33.0 ± 11.2 μm in length) were
observed in the intercellular space, and small crystals
(5.6 ± 1.6 μm in diameter) were located around the cells.
During warming of the sample, the start of crystal
melting was visually observed at –60 °C, with expansion
of the individual channels and receding of individual
crystals from each other. Gas bubbles between the crys-
tals enlarged (indicated by arrows in the figure). At a
temperature of –6.9 °C melting of the crystals termi-
nated and the gas bubbles were fully dissolved.
Cyclical fluctuations in the temperature range between
–80 °C and –100 °C did not result in significant changes
in cell size, size of the cell aggregates, crystals, and chan-
nels. Changes in the transparency of the crystals were
observed which may be due to equipment characteris-
tics. An increase in the size of gas bubbles was observed
during lowering of the temperature, which may be asso-
ciated with a decrease in the ice volume (Fig. 3).
Viability, state, and functional parameters of the cells
Analysis of cell number after frequent temperature fluc-
tuations in the samples shows that a decrease depended
on the number of temperature cycles and did not de-
pend on the range of temperature variations. A statisti-
cally significant decrease was observed only after 30–40
cycles of temperature fluctuations (Fig. 4a).
Analysis with trypan blue staining demonstrated a de-
crease in the cell survival depending on the number of
cycles as well as on the temperature range. Cell survival
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at temperature fluctuations down to –80 °C decreases
most drastically, whereas the temperature fluctuations to
–100 °C and –150 °C are not significantly different to
each other (Fig. 4b.).
Flow cytometry with Anexin V and PI, which allows us
to distinguish necrotic and apoptotic events, indicates that
cell viability after temperature fluctuations decreases sig-
nificantly, and to a greater degree at fluctuations to –80 °C
than to –150 °C or –100 °C, with significance reached
after 10 cycles of temperature fluctuation. Apoptotic
changes in cells are minor, but more pronounced with
temperature fluctuations to –80 °C (Table 1).
The ability of the cells to adhere to plastic 24 h after
thawing was performed as a functional test. It was
shown that the adhesive properties of the cells were sig-
nificantly compromised after temperature fluctuations
during cryopreservation (Fig. 5). Counting the cells that
adhered 24 h after thawing revealed a drop similar to
Fig. 1 Characterization of primary cell culture derived from placenta for MSC origin. a RT-PCR analysis for expression of typical MSC markers: cells
provide a signal for CD90, CD73, CD105, CD106, and CD166 genes while being negative for CD34, CD45, and MHC class II. b Differentiation potential
of primary cell culture derived from placenta into lineages of MSC origin: adipogenic (Oil Red O staining); chondrogenic (Alcian blue staining); and
osteogenic (Von Kossa staining). Cells expanded in standard MSC culture medium were considered as a negative control. Scale bars= 50 μm
Fig. 2 Thermograms of temperature fluctuations within the studied samples. Dynamics of temperature changes in multiple cycles of the
temperature ranges: a between –196 °C and –80 °C; b between –196 °C and –100 °C; c between –196 °C and –150 °C
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the tendency for cell survival (Fig. 5a). Figure 5b demon-
strates a typical visual example of the cells 24 h after
seeding: the cells after 50 cycles in the highest range of
temperature fluctuations (–196 °C to –80 °C) display
highly compromised adhesive properties (Fig. 5b2) in
comparison to samples stored at constant temperatures
(Fig. 5b1), or to the native control without cryopreserva-
tion (Fig. 5b3). Multiple floating nonadhered cells can be
seen (Fig. 5b2).
Analysis of cellular parameters with the MTT test
demonstrated that the metabolic activity of the cells
after thawing depends both on the range of
temperature fluctuation and on the number of fluctu-
ations. MTT reduction was highest at temperature
fluctuations down to –80 °C (Fig. 6a). At the same
time, metabolic activity did not significantly decrease
with temperature fluctuations down to –100 °C and –
150 °C, at least within 30 cycles.
Fig. 3 Cryomicroscopic analysis of crystal formation during temperature fluctuations. Freezing of placental MSCs from 0 °C to –100 °C and
thawing from –100 °C to –6.7 °C from left to right, top to bottom (the temperature is indicated on each image). a Samples at –80 °C during the
first cycle of temperature fluctuations; b samples at –100 °C during the last cycle of temperature fluctuations; c samples at –80 °C during the last
cycle of temperature fluctuations. Arrows indicate the change of inclusions. Scale bars = 20 μm
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Resazurin reduction also allows evaluation of the mito-
chondrial metabolic activity in the cells [30]. Metabolic ac-
tivity measured with reduction of resazurin after
temperature fluctuations dropped in a manner similar to
the activity of the MTT test (Fig. 6b). There were no sig-
nificant changes until 20 cycles of temperature fluctua-
tions in any of the studied temperature ranges; significant
changes occur after 40–50 cycles in the fluctuation range
up to –80 °C.
Differentiation potential of placental MSCs after
temperature fluctuations during low temperature storage
Analyzed samples were able to differentiate into adipo-
genic, chondrogenic, and osteogenic lineages after
Fig. 4 Cell count and cell survival after cryopreservation procedures. a The number of cells in the studied samples, depending on the number of
temperature fluctuations. b Cell survival after temperature fluctuations by trypan blue staining. *p < 0.05, versus samples with no
temperature fluctuations
Table 1 Flow cytometry with Annexin V and PI for analysis of necrotic and apoptotic processes in the cells after the studied
cryopreservation procedures (mean ± SD)













83.88 ± 3.7 1.02 ± 0.05 1.33 ± 0.89 13.7 ± 1.7
Temperature fluctuations
between –196 °C and –80 °C
5 cycles 82.7 ± 2.1 1.19 ± 0.03 2.21 ± 0.8* 14.66 ± 2.0
10 cycles 68.2 ± 2.1* 1.12 ± 0.02 2.1 ± 0.09* 27.98 ± 2.2*
20 cycles 56.8 ± 1.5* 0.54 ± 0.01 2.5 ± 0.08* 41.47 ± 3.82*
30 cycles 54.2 ± 3.1* 1.01 ± 0.02 3.05 ± 0.09* 42.68 ± 2.09*
40 cycles 52.5 ± 1.8* 0.72 ± 0.02 2.65 ± 0.15* 43.64 ± 1.28*
50 cycles 51.8 ± 1.9* 0.86 ± 0.01 1.83 ± 0.05* 46.22 ± 2.38*
Temperature fluctuations
between –196 °C and –100 °C
5 cycles 81.6 ± 2.8 0.48 ± 0.02 1.67 ± 0.06 16.09 ± 1.44
10 cycles 80.2 ± 2.9 0.58 ± 0.02 2.17 ± 0.07* 17.47 ± 1.88*
20 cycles 72.0 ± 2.5* 0.89 ± 0.01 2.03 ± 0.02* 26.05 ± 3.54*
30 cycles 70.6 ± 3.1* 1.18 ± 0.02 2.96 ± 0.05* 24.11 ± 4.37*
40 cycles 64.8 ± 2.4* 0.65 ± 0.04 3.23 ± 0.01* 25.96 ± 2.78*
50 cycles 59.6 ± 3.3* 1.6 ± 0.01 1.15 ± 0.01 38.94 ± 3.64*
Temperature fluctuations
between –196 °C and –150 °C
5 cycles 88.37 ± 2.7 0.55 ± 0.01 1.94 ± 0.01 11.82 ± 3.02
10 cycles 83.6 ± 1.8 0.83 ± 0.07 1.8 ± 0.09 13.64 ± 1.1
20 cycles 80.02 ± 3.2 0.57 ± 0.06 1.59 ± 0.03 17.68 ± 2.81
30 cycles 78.79 ± 4.5* 0.34 ± 0.02 1.57 ± 0.03 19.30 ± 0.77*
40 cycles 70.39 ± 4.1* 0.98 ± 0.02 1.3 ± 0.03 25.46 ± 3.39*
50 cycles 64.49 ± 3.6* 0.96 ± 0.08 1.6 ± 0.05 27.74 ± 2.7*
*p < 0.05, versus constant cryopreservation temperature control
PI propidium iodide
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cryopreservation with temperature fluctuations that
mimic long-term storage, visually identically to the sam-
ples stored at constant temperature as well as to the native
noncryopreserved control, also used in the MSC
characterization (Fig. 1). However, microarray analysis of
34,127 genes revealed that nearly 0.38% of all studied
genes in adipogenic, 0.24% in chondrogenic, and 0.35% in
osteogenic lineages were either upregulated or downregu-
lated more than twofold and up to tenfold in the samples
differentiated without cryopreservation procedures in
comparison to the samples differentiated after cryopreser-
vation at the constant temperatures (Additional file 2).
Interestingly, the gene-specific regulation pattern was very
different in the samples differentiated after cryopreserva-
tion with thermal cycles (Additional file 2). In percentage
values, 3.08% of genes in adipogenic, 0.35% in chondro-
genic, and 0.95% in osteogenic lineages were either upreg-
ulated or downregulated more than twofold and up to
tenfold in comparison to the samples differentiated with-
out cryopreservation procedures (Additional file 2). More-
over, 41 genes were regulated more than 10-fold in the
samples differentiated after cryopreservation procedures
in comparison to native cell differentiation (Fig. 7). In fu-
ture studies, quantitative differentiation assays after
Fig. 5 Adhesive properties of the cells 24 h after cryopreservation with constant temperatures and temperature fluctuations. a Number of cells
capable of adhering to plastic 24 h after thawing. b Typical example of cellular adherence after studied cryopreservation procedures: 1 samples
stored at constant temperatures; 2 samples after 50 cycles in the range of temperature fluctuations between –196 °C and –80 °C; 3 native control
without cryopreservation. Scale bars = 100 μm
Fig. 6 Metabolic and proliferation activity of the cells after cryopreservation procedures. a MTT test for placental MSCs after temperature fluctuations.
b Resazurin reduction test for placental MSCs after temperature fluctuations. *p < 0.05, versus samples with no temperature fluctuations
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temperature fluctuations should be evaluated for better
understanding of the impact on such processes.
Analysis of the influence of temperature fluctuations during
low temperature storage on transgene expression in
placental MSCs
Cryopreservation with 50 cycles of temperature fluctua-
tions between –196 °C and –80 °C was chosen to evalu-
ate the influence on transgene expression in placental
MSCs as the condition with the most pronounced effect
on the other studied parameters. Two independent
groups of studied cells were transduced with different
constructs with GFP as a reporter gene. The samples
were evaluated 24 h after recovery from cryopreserva-
tion conditions, or 24 h after repassaging in the case of
noncryopreserved control. Neither cryopreservation
under constant temperature conditions nor temperature
fluctuations during cryopreservation have a significant
impact on the expression of transgene constructs in our
sample groups (Fig. 8). Therefore, no concerns about
transgene expression emerge during long-term cryo-
preservation of placental MSCs.
Discussion
The use of real low-temperature banks for biological ob-
jects is often accompanied by certain temperature fluc-
tuations associated with a variety of handling events,
manipulations of the stored samples, transportation, etc.
An accumulation of occurrence of such events in the
long term may result in alterations within the samples
which may compromise the outcome of cryopreserved
material [23–25]. This is especially important for
patient-specific material or for stocks of frozen samples
intended for use in regenerative medicine which can be
stored for decades prior to actual application. Placental
MSCs are among the most highly prolific as well as
already practically applied cell types which fall into this
category [7–9, 31].
In this study we aimed to analyze a wide range of pa-
rameters of placental MSCs with regard to the effect of
mimicked long-term cryopreservation accompanied by
temperature fluctuations in the samples. We developed a
model that allows modeling of the oscillations of
temperature inherent to the probable events in a prac-
tical biobank. The lower end temperature in our
Fig. 7 Microarray analysis of gene regulation after cryopreservation procedures. Gene regulation in the samples differentiated after cryopreservation
procedures with constant temperatures and temperature fluctuations in comparison to the native cell differentiation. Genes with over tenfold
regulation. Adipo adipogenic, Chondro chondrogenic, Osteo osteogenic
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experiments was –196 °C (liquid nitrogen storage
temperature) and the upper end temperatures were –
150 °C, –100 °C, and –80 °C. The upper end tempera-
tures mimicked the range found in available mechanical
cryogenic freezers, dry ice, and liquid nitrogen steam
storage, which could contribute to temperature fluctua-
tions during practical long-term biobanking.
The cryomicroscopic studies involved a range of
temperatures which additionally included thawing
points. Cycles of temperature fluctuations were per-
formed only in the –100 °C to –80 °C range due to
limitations of equipment parameters. Cryomicroscopy
revealed that melting of the ice crystals and expan-
sion of the channels in between them starts at tem-
peratures above –60 °C to –50 °C. Changes associated
with melting could be observed at temperatures above
–40 °C to –30 °C, which is consistent with our previ-
ous studies [18] showing that a sufficient cell survival
rate requires at least –40 °C end temperature during
slow freezing. Temperature fluctuations within –80 °C
to –100 °C resulted in minor changes related to ice
volume alterations. Additional studies are necessary
for a deeper understanding of the role of temperature
fluctuations on cell damage caused by crystal
formation.
Vital parameters, which characterize structural and
functional conditions of the cells after thawing, have
been used to analyze the influence of temperature fluc-
tuations during cryopreservation. The majority of sur-
vival rates provided in cryopreservation protocols are
based on trypan blue staining data, which mainly indi-
cate the membrane integrity and efficiency of efflux
pumps [32]. However, early necrotic and apoptotic
events in the cells cannot be distinguished by such an
approach, while vital parameters might already be irre-
versibly compromised by cryodamage. Therefore, in
addition to the classic Coulter Counter method of try-
pan blue staining, we evaluated the cells with the flow
cytometric Annexin V apoptosis detection kit with PI,
which allowed us to differentiate between the contribu-
tion of necrosis and apoptosis on cell survival [33]. Add-
itionally, the ability of the cells to adhere to plastic after
post-thawing recovery was performed as a functional
test. We observed a significant decrease in the adhesive
properties of the cells stored with temperature fluctua-
tions that mimic long-term biobanking. This also corre-
sponds with the observations of other authors who
analyzed the actual storage of MSCs for over 20 years
[34]. Such an effect may be associated with the observed
necrotic and apoptotic events, triggered in the cells by
Fig. 8 Influence of temperature fluctuations on transgene expression in placental MSCs. Cells with expressed transgene after 24-h recovery from
the studied cryopreservation conditions: a lentiviral expression vector construct pRRL.PPT.T11.EGFP.hPGK.M2.pre with green fluorescent protein
(GFP) as a reporter gene; b lentiviral expression vector pLVTHM with GFP as a reporter gene; c typical example of expression of transgenic vector
with GFP reporter
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repeated thermal cycles, as well as with the utilization of a
large amount of metabolic sources for recovery processes
after the stress accumulated during cryopreservation [35].
Analysis of the metabolic condition of the studied cells
after thawing showed similar patterns in MTT and resa-
zurin reduction tests. Certain variances between the re-
sults of the MTT test and resazurin reduction test may
be explained by methodological peculiarities connected
with a different incubation period of reagent compo-
nents (being 4 hours and 24 h, respectively).
The data analysis allows us to conclude that
temperature fluctuations within –196 °C to –150 °C result
in significant changes in the quantity, viability, and func-
tional activity of placental MSCs after 20 cycles; apoptotic
changes in this case are not observed. Significant changes
at more than 20 cycles are also observed after temperature
fluctuations within –196 °C to –100 °C. However, the
quantity, viability, and functional activity of placental
MSC do not differ significantly from those parameters
after temperature fluctuations within –196 °C to –150 °C.
Interestingly, impact of the temperature fluctuations
between –196 °C and –80 °C on the quantity, viability,
and metabolic activity of placental MSCs is significantly
different in comparison to constant temperature, and is
more pronounced than in the –196 °C to –150 °C and –
196 °C to –100 °C ranges.
Numerous research groups have demonstrated the cap-
ability of placental MSCs to differentiate after cryopreser-
vation [27, 36]. A study of the parameters of bone marrow
MSCs after 20 years of cryopreservation was able to differ-
entiate them into osteoblasts, adipocytes, and neuronal
cells [34]. We were also able to differentiate the cells after
cryopreservation with temperature fluctuations into three
mesenchymal lineages, which were visually identical to the
noncryopreserved control and to the samples with con-
stant cryopreservation temperature conditions. However,
microarray analysis revealed patterns of gene regulation
that were different between the samples cryopreserved at
constant temperatures and those with temperature fluctu-
ations. Such gene regulation did not visually affect the
outcome of the differentiation procedures in any of the
three differentiation lineages; however, this effect requires
further analysis. Interestingly, gene regulation of differen-
tiated cells after cryopreservation with thermal cycling
was highly expressed in the adipogenic lineage: the num-
ber of genes with minor regulations (from twofold up to
tenfold) was almost an order of magnitude higher in
comparison to noncycled samples, while 37 genes were
regulated more than 10-fold and in one case more than
100-fold in comparison to native cell differentiation. Such
an effect should be considered and studied in cases of adi-
pogenic differentiation after long-term cryopreservation,
as well as analysis of the functional characteristics of the
highly upregulated genes.
Since a wide range of genome manipulations is applied
these days in biomedical research, we also aimed to
analyze the influence of temperature fluctuations in our
model on the levels of expression of transgene vectors.
Other researchers demonstrate that cryopreservation
does not affect expression of a transgene [26]. This was
also confirmed in our study.
In summary, a developed model mimicking possible
events in long-term practical biobanking by repeated
temperature fluctuations in cryopreserved samples
allowed us to rapidly evaluate changes in placental
MSCs. Certain alterations in comparison with material
stored at constant temperature were observed. Such a
model can be considered in the studies of long-term
preservation of other biological objects which would
help develop further strategies and evaluate potential
limitations.
Conclusions
Significant structural changes in the ice crystals and
channels were detected during our cryomicroscopy study
in the temperature range above –40 °C. At temperature
fluctuations below –80 °C, slight changes in the inclu-
sion and the transparency of the crystals were observed.
The total number of cells, viability, and metabolic and
apoptotic parameters of placental MSCs did not signifi-
cantly differ from controls with temperature fluctuations
in the range of –196 °C to –100 °C in less than 20 cycles.
Increasing the number of cycles, as well as the
temperature fluctuation range to –80 °C, leads to signifi-
cant lowering of cell number, viability, and metabolic
characteristics after thawing. The number of apoptotic
changes increases depending on the number of cycles of
temperature fluctuation.
The adhesive properties of MSCs after thawing are sig-
nificantly compromised in the cells that were cryopre-
served with temperature fluctuations in comparison to
cryopreservation with the constant end temperatures.
Short-term temperature fluctuations to –100 °C,
possible during practical storage of placental MSCs in
low-temperature biobanks, do not significantly affect the
cellular characteristics. Temperature fluctuations up to –
80 °C lead to compromise of cell culture properties.
The possibility of placental MSCs differentiating into
mesenchymal lineages is not compromised after cryo-
preservation with a constant end temperatures as well as
after cryopreservation with temperature fluctuations in
comparison to native cells. However, regulation of vari-
ous genes after cryopreservation procedures significantly
varies in differentiated cells.
Transgene expression is not compromised after cryo-
preservation with a constant end temperature as well as
after cryopreservation with the studied range of
temperature fluctuations in comparison to native cells.
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Therefore, temperature fluctuations in the samples,
typically inherent to practical biobanking, should be
considered during long-term cryostorage of placental
MSCs. While the differentiation potential of these cells
is not significantly compromised, alterations in vital pa-
rameters and gene regulation are observed. This should
be especially considered for any future clinical applica-
tion of placental MSCs in the field of regenerative medi-
cine. The development of strategies for avoiding such
temperature fluctuations is feasible and should not be
overlooked.
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